> top > docs > PubMed:32178765 > spans > 0-206 > annotations

PubMed:32178765 / 0-206 JSONTXT

Annnotations TAB JSON ListView MergeView

Inflammaging

Id Subject Object Predicate Lexical cue
T1 0-206 Sentence denotes Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial.
T1 0-206 Sentence denotes Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial.

yaoziqian_800_3

Id Subject Object Predicate Lexical cue
T1 0-10 CI denotes Guselkumab
T2 35-54 DP denotes psoriatic arthritis
T25 173-180 CI denotes placebo

Zierdiyeerkenaili_800_3

Id Subject Object Predicate Lexical cue
T1 0-10 CI denotes Guselkumab
T5 35-54 DP denotes psoriatic arthritis
T19 173-180 CI denotes placebo